Skip to content

Clinical trials

Completed Phase 1 Coronary Artery Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronary Artery Disease Phase: Phase 1 Status: Completed Clear all

71 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20023
20041
20051
20066
20078
20084
20093
20108
20113
20126
20133
20152
20161
20171
20185
20193
20202
20214
20223
20231
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed71

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca6
Bayer3
Mayo Clinic3
Washington University School of Medicine3
Chong Kun Dang Pharmaceutical2
Cytori Therapeutics2
Eli Lilly and Company2
Fluoropharma, Inc.2
Ottawa Heart Institute Research Corporation2
Sinotau Pharmaceutical Group2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Artery Disease71
Cardiovascular Diseases7
Myocardial Infarction7
Coronary Disease6
Heart Failure3
Acute Coronary Syndrome2
Arteriosclerosis2
Atherosclerosis2
Diabetes Mellitus2
Heart Diseases2

Trials

Showing 1 to 25 of 71. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.